This is an old revision of this page, as edited by Aspro (talk | contribs) at 13:28, 2 September 2006 (added cite). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 13:28, 2 September 2006 by Aspro (talk | contribs) (added cite)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)A Norepinephrine-dopamine reuptake inhibitor is a class of drugs that is both:
An example is Bupropion.
This medical treatment–related article is a stub. You can help Misplaced Pages by expanding it. |
References
- Stephen M. Stahl, M.D., Ph.D.; et al. (2004). "A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor" (pdf). Journal of Clinical Psychiatry; 6(04) 159-166 2004 PHYSICIANS POSTGRADUATE PRESS, INC. Retrieved 2006-09-02.
{{cite journal}}
: Cite journal requires|journal=
(help); Explicit use of et al. in:|author=
(help); Italic or bold markup not allowed in:|publisher=
(help)CS1 maint: multiple names: authors list (link)